Ken Griffin Coeptis Therapeutics Hldgs Inc Transaction History

Citadel Advisors LLC

  • $618 Billion
  • Q3 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Coeptis Therapeutics Hldgs Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 10,059 shares of COEPW stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,059
Holding current value
$0
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
N/A
10,059 New
10,059 $0
Q1 2025

May 15, 2025
BUY
N/A
689 Added 6.18%
11,834 $0
Q4 2024

Feb 14, 2025
SELL
N/A
-638 Reduced 5.41%
11,145 $0
Q3 2024

Nov 14, 2024
BUY
N/A
253 Added 2.19%
11,783 $0
Q2 2024

Aug 14, 2024
BUY
N/A
100 Added 0.87%
11,530 $0
Q1 2024

May 15, 2024
BUY
N/A
11,430 New
11,430 $0

Others Institutions Holding COEPW

# of Institutions
14
Shares Held
553K
Call Options Held
0
Put Options Held
0
View Full List

About COEPTIS THERAPEUTICS HLDGS INC

COEPW Quotes by TradingView
  • Ticker COEPW
More about COEPW
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email